ANKRD45: A RNA-Protein Interaction Protein (G339416)

Target Name: ANKRD45

NCBI ID: G339416

ANKRD45

ANKRD45: A RNA-Protein Interaction Protein

ANKRD45 (RNA-protein interaction database), also known as RP3-436N22.4, is a protein that is involved in various cellular processes in the human body. Its primary function is to interact with RNA molecules and play a role in the regulation of gene expression. ANKRD45 is a RNA-protein interaction protein, which means it consists of both RNA and protein components. It is a 22.4 kilodalton protein, and its activity is primarily demonstrated in its ability to interact with specific RNAs.

The ANKRD45 protein is a key regulator of gene expression and has been shown to play a role in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. Its interaction with RNA molecules allows it to regulate gene expression by affecting the stability and translation of specific RNAs. ANKRD45 has been shown to interact with a wide range of RNAs, including coding RNAs, non-coding RNAs, and smallRNAs.

One of the unique features of ANKRD45 is its ability to form double-stranded RNA structures. This interaction with RNA molecules allows ANKRD45 to regulate the stability and translation of specific RNAs by affecting the formation of double-stranded RNA structures. This regulation plays a critical role in the regulation of gene expression and is a key mechanism by which ANKRD45 influences cellular processes.

Another important function of ANKRD45 is its role in apoptosis. Apoptosis is a natural process that is essential for the regulation of cellular life cycle and has been implicated in various diseases, including cancer. ANKRD45 has been shown to play a role in the regulation of apoptosis by affecting the stability and translation of specific RNAs that are involved in the regulation of apoptosis.

In addition to its role in apoptosis, ANKRD45 has also been shown to play a role in cell growth. Cell growth is a critical process that is essential for the development and maintenance of cellular organisms. ANKRD45 has been shown to regulate the stability and translation of specific RNAs that are involved in the regulation of cell growth, which is a key mechanism by which ANKRD45 influences cellular processes.

The ANKRD45 protein is also involved in the regulation of transcriptional regulation. Transcriptional regulation is the process by which RNA molecules are translated from DNA into proteins. ANKRD45 has been shown to interact with specific RNAs and regulate their stability and translation, which is a key mechanism by which ANKRD45 influences cellular processes.

In conclusion, ANKRD45 is a protein that is involved in various cellular processes in the human body. Its primary function is to interact with RNA molecules and play a role in the regulation of gene expression, apoptosis, cell growth, and transcriptional regulation. ANKRD45 is a RNA-protein interaction protein, which means it consists of both RNA and protein components. Its activity is primarily demonstrated in its ability to interact with specific RNAs and its role in regulating cellular processes. Therefore, ANKRD45 is a potential drug target and a biomarker for various diseases.

Protein Name: Ankyrin Repeat Domain 45

Functions: May play a role during cell division

The "ANKRD45 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD45 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets